Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Toward the rational design of protein kinase casein kinase-2 inhibitors.
|
Pharmacol Ther
|
2002
|
1.15
|
2
|
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17.
|
Purinergic Signal
|
2011
|
0.90
|
3
|
N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
|
J Med Chem
|
2007
|
0.89
|
4
|
Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
|
J Med Chem
|
2009
|
0.89
|
5
|
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
|
Bioorg Med Chem
|
2009
|
0.87
|
6
|
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
|
Bioorg Med Chem
|
2007
|
0.86
|
7
|
Highlights on the development of A(2A) adenosine receptor agonists and antagonists.
|
ChemMedChem
|
2007
|
0.81
|
8
|
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1.
|
Anal Biochem
|
2011
|
0.80
|
9
|
Evidence for the existence of a specific g protein-coupled receptor activated by guanosine.
|
ChemMedChem
|
2011
|
0.79
|
10
|
Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists.
|
Curr Med Chem
|
2015
|
0.79
|
11
|
Adenine-based acyclic nucleotides as novel P2X3 receptor ligands.
|
J Med Chem
|
2009
|
0.78
|
12
|
Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.
|
Bioorg Med Chem
|
2008
|
0.77
|
13
|
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
|
Bioorg Med Chem
|
2011
|
0.77
|
14
|
Interaction model for anthracycline activity against DNA topoisomerase II.
|
Biochemistry
|
2004
|
0.77
|
15
|
Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease.
|
ChemMedChem
|
2009
|
0.77
|
16
|
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists.
|
Eur J Med Chem
|
2013
|
0.76
|
17
|
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile.
|
Purinergic Signal
|
2007
|
0.75
|
18
|
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
|
J Med Chem
|
2008
|
0.75
|
19
|
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies.
|
Bioorg Med Chem
|
2012
|
0.75
|
20
|
Overview on Radiolabel-Free in vitro Assays for GPCRs.
|
Mini Rev Med Chem
|
2017
|
0.75
|
21
|
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
|
Bioorg Med Chem
|
2008
|
0.75
|
22
|
Identification of alpha1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens.
|
Eur J Pharmacol
|
2008
|
0.75
|
23
|
Pharmacological postconditioning of the rabbit heart with non-selective, A1 , A2A and A3 adenosine receptor agonists.
|
J Pharm Pharmacol
|
2014
|
0.75
|
24
|
Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonists.
|
Nucleosides Nucleotides Nucleic Acids
|
2007
|
0.75
|
25
|
Synthesis and stability studies of 2',3',5'-tri-O-acetyl-2-amino(-N6-cyclopentyl)-1-deazaadenosines.
|
Nucleosides Nucleotides Nucleic Acids
|
2007
|
0.75
|